Elmiron Side Effects
Diarrhea, hair loss, nausea, abdominal pain and headaches are common side effects of Elmiron. In June 2020, Janssen Pharmaceuticals added a warning for retinal pigmentary maculopathy, a condition that causes vision problems.
Common Side Effects of Elmiron
Most Elmiron side effects are mild and stop after the body gets used to the medication. Many people tolerate the medication well. Vision loss symptoms from Elmiron vary but here are the most common symptoms. Some long-term users of Elmiron have experienced vision problems.
- Abdominal pain
- Blood in the stool
- Bruising
- Dehydration
- Depression
- Diarrhea
- Dizziness
- Hair loss
- Headache
- Nausea
- Rash
- Upset stomach
Researchers studied Elmiron side effects in 2,627 patients, according to the drug’s prescribing information. Common side effects occurred in 1% to 4% of participants. Thirty-three patients, about 1.3%, suffered serious side effects. Six patients died, but other health problems appear to have caused the deaths.
The most common side effect reported was hair loss, or alopecia. Hair loss began in the first four weeks of treatment. About 97% of patients experienced hair loss in a single spot. Hair loss stopped for most patients and hair grew back after they discontinued using the drug.
In an unblended clinical trial of 2,499 patients with interstitial cystitis, the most prevalent side effects included hair loss (4%), diarrhea (4%), nausea (4%), headache (3%) and rash (3%).
In clinical trials, a year was the longest researchers followed trial participants.
Does Elmiron Cause Weight Gain?
As of June 2020, Elmiron’s prescription information does not list weight gain as a side effect.
However, an October 2017 patient flyer says that “weight gain and swelling caused by fluid buildup have been reported in patients taking Elmiron.”
In animal study data, mice who took higher doses of the drug had a “significant increase (40%) in body weight gain,” according to a March 2016 assessment report of Elmiron by the European Medicines Agency.
Learn more about Elmiron and how to take legal action if you developed vision problems after taking the drug.
Get Your Free Guide
Rare Elmiron Side Effects
According to the drug’s prescribing information, rare side effects happened in 1% or less of the trial participants.
- Allergic reactions and photosensitivity
- Anemia and other blood abnormalities
- Cold-like symptoms
- Colitis constipation
- Conjunctivitis (pink eye)
- Itchy skin
- Mouth ulcers
- Retinal hemorrhage
- Ringing in the ears (tinnitus)
- Shortness of breath
- Vomiting
Rectal Hemorrhage
In a phase 4 study of 128 patients, eight patients (6.3%) who took the daily 300 mg dose experienced rectal hemorrhage. Most patients described it as mild. Fifteen percent of patients who took a 900 mg dose had a higher incidence of rectal bleeding.
Abnormal Liver Function
In a phase 2 study, six out 51 patients (11.8%) had increases in their liver function tests with a daily dose of 900 mg.

Vision Damage
In June 2020, Janssen Pharmaceuticals added a warning for retinal pigmentary changes, also known as pigmentary maculopathy, associated with long-term Elmiron use. Increased dose and length of use appear to be risk factors.
The cause of the disease is not clear. Most cases happened in people who used the drug for three years or longer, but people who used the drug for shorter durations have also reported symptoms.
- Slow adjustment to low light
- Difficulty reading
- Blurred vision
The prescribing information recommends vision tests within six months of starting treatment and periodic tests after that. Some people continued to have progressive vision damage after stopping treatment.
One March 2022 study in the British Journal of Clinical Pharmacology found that people who used Elmiron for more than three years had a 9.5-fold increased risk of maculopathy compared to a 2.3-fold increased risk with use of one year or less.
People who experienced vision damage filed Elmiron lawsuits against Janssen Pharmaceuticals. Lawsuits claim the drugmaker failed to warn them about the risk.
Elmiron Side Effects Reported to FDA
A search of the postmarketing data available on the FDA Adverse Event Reporting System (FAERS) Public Dashboard for “Elmiron” and “pentosan polysulfate sodium” from 1997 to June 30, 2020, showed 2,570 adverse event reports.
Of those reports, 1,748 were serious, including 24 deaths. Data on FAERS comes from voluntary reports and the FDA cannot verify if the adverse event was related to drug use. There were 202 eye disorders reported. These included maculopathy, visual impairment and blurred vision.
- Alopecia, 252
- Headache, 173
- Diarrhea, 166
- Nausea, 156
- Dizziness, 120
Calling this number connects you with a Drugwatch representative. We will direct you to one of our trusted legal partners for a free case review.
Drugwatch's trusted legal partners support the organization's mission to keep people safe from dangerous drugs and medical devices. For more information, visit our partners page.